121) The patient had a history of hypertension, dia |
122) One patient had a secondary revision of the do |
123) 97 cases of stage III and IV COPD, only 1 patient had accepted long-term home oxygen |
124) The patient had an uneventful postoperative pe |
125) mph nodes attended three patients and one patient had deep lymph nodes. |
126) rther questioning, it transpired that the patient had discontinued his warfarin on p |
127) Another patient had giant LL measuring 30 × 30 × |
128) ridement with delayed reconstruction, the patient had healed well. |
129) The patient had hypertensive peaks on a 24-h r |
130) This patient had hypoacusis, exophthalmos and f |
131) One patient had large LL measuring 10 × 9 × |
132) status with no other mutation, while one patient had no mutation(s). |
133) The patient had non-specific laboratory inflam |
134) ts had invasive ductal carcinoma, and one patient had noninvasive ductal carcinoma o |
135) Marked MRI osteitis, found in 1 patient, had disappeared at 12 months. |
136) We encountered a patient who developed CME during treatment |
137) We present a patient who developed a parotid fistula as |
138) We report on a 19-year-old patient who developed negative pressure pu |
139) ortant in the presurgical evaluation of a patient who is being considered for placem |
140) We report on a 67-year-old female patient who presented with an acute ischem |
141) We report the case of a black women patient who presents a resistance to aceno |
142) ase of orolingual edema and bleeding in a patient who received rtPA for acute ischem |
143) of Vieussens' arterial ring aneurysm in a patient who underwent coronary computed to |
144) e collapsed into the maxillary sinus in 1 patient who underwent iliac bone graft on |
145) We describe a patient who was diagnosed with flare up of |
146) Here, we present a 50-year-old female patient, who presented to our clinic with |
147) The other patient, who received luteinizing hormone- |
148) shows promise for enhancing collaborative patient care and access to PC. |
149) owing professional protocols prioritizing patient care and professional accountabili |
150) ly to view such standards as a barrier to patient care. |
151) s a case for engaging with SNS to improve patient care. |
152) y of nurses and ultimately the quality of patient care. |
153) ns for regulatory decisions and long-term patient care. |
|